Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1067 of 1,261
  1. US 7332172

    Transformed bacteria producing CS6 antigens as vaccines

    The United States of America as represented by the Secretary of the Army · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  2. US 7331920

    Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  3. US 7332170

    Classical swine fever virus virulence determinant and a novel classical swine fever vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  4. US 7332159

    Method and composition for inhibiting reperfusion injury in the brain

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  5. US 7332645

    IL-21 as a regulator of immunoglobin production

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  6. US 7332602

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  7. US 7332612

    Amorphous and crystalline forms of losartan potassium and process for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  8. US 7332590

    Molecular characteristics of non-small cell lung cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  9. US 7332471

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  10. US 7332224

    Cleaning article containing hydrophilic polymers

    ReGenesis Group · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  11. AU 2007283667

    Genes and proteins of Brachyspira hyodysenteriae and uses thereof

    SPIROGENE PTY LTD [DE] · Granted Feb 14, 2008 · Expires Feb 9, 2028

    granted
  12. US 7329681

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  13. US 7329652

    Diaminotriazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  14. US 7329759

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  15. US 7329680

    Heterocycle substituted carboxylic acids

    The Institute for Pharmaceutical Discovery, LLC · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  16. US 7329638

    Drug delivery compositions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  17. US 7329511

    Nucleic acid encoding GAD65

    The Regents of the University of California · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  18. US 7329752

    Carbamate compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  19. US 7329502

    ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  20. US 7329642

    β-2-glycoprotein is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  21. US 7329401

    Cyclooxygenase-2 selective agents useful as imaging probes and related methods

    The Regents of the University of California · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  22. US 7329721

    Maleamic acid polymer derivatives and their bioconjugates

    Nektar Therapeutics AL, Corporation · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  23. US 7329672

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  24. US 7329671

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.